Xinke Medical Recognized as a National High-Tech Enterprise

In 2018, Zhejiang Xinke Medical Technology Co., Ltd. successfully passed the National High-Tech Enterprise accreditation, thanks to its sustained innovation and technical expertise in the field of in vitro diagnostic reagents.

Accreditation Criteria

National High-Tech Enterprise accreditation imposes strict requirements on companies:

core independent intellectual property rights

the ability to commercialize scientific and technological achievements

R&D organization and management capability

growth indicators

Xinke Medical met all of these criteria, fully demonstrating its technological strength and capacity for innovation.

Innovation Achievements

In recent years, Xinke Medical has achieved a number of innovation milestones:

obtained multiple invention patents and utility model patents

developed 15 major categories of IVD reagent products

established a complete quality management system

built a professional R&D team

Development Plans

After receiving this recognition, Xinke Medical will continue to increase its R&D investment:

strengthen cooperation with universities and research institutes

attract high-caliber technical talent

expand new product lines

enhance independent innovation capabilities

The company will take this recognition as a new starting point to deliver better products and services to its customers.